Zimmer Biomet Holdings Other Income (Expense) decreased by 119.5% to -$3.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 203.4%, from $2.90M to -$3.00M. Over 3 years (FY 2022 to FY 2025), Other Income (Expense) shows an upward trend with a -41.6% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $8.00M | $300.00K | -$56.10M | -$42.60M | -$25.40M | -$3.90M | $7.70M | -$1.20M | $3.80M | -$19.60M | -$100.00K | $2.00M | $5.10M | -$38.10M | $2.90M | $3.90M | $3.30M | $15.40M | -$3.00M |
| QoQ Change | — | -96.3% | <-999% | +24.1% | +40.4% | +84.6% | +297.4% | -115.6% | +416.7% | -615.8% | +99.5% | >999% | +155.0% | -847.1% | +107.6% | +34.5% | -15.4% | +366.7% | -119.5% |
| YoY Change | — | — | — | -632.5% | <-999% | — | +113.7% | +97.2% | +115.0% | -402.6% | -101.3% | +266.7% | +34.2% | -94.4% | >999% | +95.0% | -35.3% | +140.4% | -203.4% |